These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33293242)

  • 1. Pharmacokinetics, pharmacodynamics and metabolism of caffeine in newborns.
    Aranda JV; Beharry KD
    Semin Fetal Neonatal Med; 2020 Dec; 25(6):101183. PubMed ID: 33293242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caffeine citrate therapy for apnea of prematurity.
    Johnson PJ
    Neonatal Netw; 2011; 30(6):408-12. PubMed ID: 22052121
    [No Abstract]   [Full Text] [Related]  

  • 3. Caffeine citrate treatment for extremely premature infants with apnea: population pharmacokinetics, absolute bioavailability, and implications for therapeutic drug monitoring.
    Charles BG; Townsend SR; Steer PA; Flenady VJ; Gray PH; Shearman A
    Ther Drug Monit; 2008 Dec; 30(6):709-16. PubMed ID: 19057373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National and international guidelines for neonatal caffeine use: Are they evidenced-based?
    Eichenwald EC
    Semin Fetal Neonatal Med; 2020 Dec; 25(6):101177. PubMed ID: 33214064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caffeine citrate: when and for how long. A literature review.
    Picone S; Bedetta M; Paolillo P
    J Matern Fetal Neonatal Med; 2012 Oct; 25 Suppl 3():11-4. PubMed ID: 23016611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caffeine Citrate Dosing Adjustments to Assure Stable Caffeine Concentrations in Preterm Neonates.
    Koch G; Datta AN; Jost K; Schulzke SM; van den Anker J; Pfister M
    J Pediatr; 2017 Dec; 191():50-56.e1. PubMed ID: 29173321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Caffeine citrate utilization for treatment of apnea in French neonatal units].
    Ducrocq S; Biran-Mucignat V; Lebas F; Baudon JJ; Gold F
    Arch Pediatr; 2006 Oct; 13(10):1305-8. PubMed ID: 16872813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caffeine Therapy in Preterm Infants: The Dose (and Timing) Make the Medicine.
    Rostas SE; McPherson C
    Neonatal Netw; 2019 Nov; 38(6):365-374. PubMed ID: 31712401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetic study of caffeine citrate in Chinese premature infants with apnea.
    Guo A; Zhu Z; Xue J; Di X; Fan J; Huang L; Zhao P; Hu X; Xie H
    J Clin Pharm Ther; 2020 Dec; 45(6):1414-1421. PubMed ID: 32737938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is caffeine available and affordable in low and middle-income countries? A survey in sub-Saharan Africa.
    Ekhaguere OA; Ayede AI; Ezeaka CV
    Semin Fetal Neonatal Med; 2020 Dec; 25(6):101182. PubMed ID: 33272903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of methylxanthine therapies for the treatment and prevention of apnea of prematurity.
    Schoen K; Yu T; Stockmann C; Spigarelli MG; Sherwin CM
    Paediatr Drugs; 2014 Apr; 16(2):169-77. PubMed ID: 24399614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of caffeine for the treatment of apnea of prematurity and bradycardia in a holoprosencephalic child with cleft lip and palate.
    Kumar M; Chawla R; Haloi P; Singh M
    J Clin Anesth; 2013 Dec; 25(8):678-9. PubMed ID: 24100116
    [No Abstract]   [Full Text] [Related]  

  • 13. Neurodevelopmental outcomes after neonatal caffeine therapy.
    Synnes A; Grunau RE
    Semin Fetal Neonatal Med; 2020 Dec; 25(6):101160. PubMed ID: 33121916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Academic Performance, Motor Function, and Behavior 11 Years After Neonatal Caffeine Citrate Therapy for Apnea of Prematurity: An 11-Year Follow-up of the CAP Randomized Clinical Trial.
    Schmidt B; Roberts RS; Anderson PJ; Asztalos EV; Costantini L; Davis PG; Dewey D; D'Ilario J; Doyle LW; Grunau RE; Moddemann D; Nelson H; Ohlsson A; Solimano A; Tin W;
    JAMA Pediatr; 2017 Jun; 171(6):564-572. PubMed ID: 28437520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caffeine citrate in the NICU.
    Flood E
    Neonatal Netw; 1989 Apr; 7(5):37-9. PubMed ID: 2704353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effects of caffeine therapy for apnea of prematurity.
    Schmidt B; Roberts RS; Davis P; Doyle LW; Barrington KJ; Ohlsson A; Solimano A; Tin W;
    N Engl J Med; 2007 Nov; 357(19):1893-902. PubMed ID: 17989382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-reported Quality of Life at Middle School Age in Survivors of Very Preterm Birth: Results From the Caffeine for Apnea of Prematurity Trial.
    Schmidt B; Anderson PJ; Asztalos EV; Doyle LW; Grunau RE; Moddemann D; Roberts RS
    JAMA Pediatr; 2019 May; 173(5):487-489. PubMed ID: 30830144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caffeine citrate: a review of its use in apnoea of prematurity.
    Comer AM; Perry CM; Figgitt DP
    Paediatr Drugs; 2001; 3(1):61-79. PubMed ID: 11220405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caffeine for apnea of prematurity.
    Bancalari E
    N Engl J Med; 2006 May; 354(20):2179-81. PubMed ID: 16707756
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacokinetics of theophylline and caffeine in premature infants with apnea (author's transl)].
    Riechert M; Lipowsky G; Stöckl H; Stiegler H
    Monatsschr Kinderheilkd; 1981 Dec; 129(12):697-702. PubMed ID: 7329425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.